Compounds > 5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein
Page last updated: 2024-09-03

5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein and dapi

5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein has been researched along with dapi in 1 studies

Compound Research Comparison

Studies
(5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein)		Trials
(5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein)		Recent Studies (post-2010)
(5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein)		Studies
(dapi)		Trials
(dapi)		Recent Studies (post-2010) (dapi)
820102,4246566

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bejjani, BA; Edward, DP; Khan, A; Li, X; Lin, S; Meghpara, B; Nakamura, H1

Other Studies

1 other study(ies) available for 5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein and dapi

ArticleYear
Human anterior chamber angle development without cell death or macrophage involvement.
    Molecular vision, 2008, Volume: 14

    Topics: Adult; Aged; Anterior Chamber; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Death; Cell Nucleus; Fetus; Fluoresceins; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Indoles; Macrophages; Middle Aged

2008